Department of Sociology and Social Anthropology, Dalhousie University, 6135 University Avenue, PO Box 15000, Halifax, Nova Scotia B3H 4R2, Canada.
Int J Drug Policy. 2013 Sep;24(5):402-11. doi: 10.1016/j.drugpo.2013.01.007. Epub 2013 Feb 27.
OxyContin(®) (Purdue Pharma, L.P., Stamford, CT) is now widely regarded as a drug of abuse fueling a larger opioid health crisis. While coverage in the North American press about OxyContin overwhelmingly focused upon the problems of related crime and addiction/misuse and the perspectives of law enforcement officials and police, coverage in those fields of medicine most intimately concerned with OxyContin-pain medicine and addiction medicine-was more nuanced.
In this article, we draw upon the constructivist social problems tradition and Hunt's theory of moral regulation in a qualitative analysis of 24 medical journal articles. We compare and contrast pain medicine and addiction medicine representations of the OxyContin problem, the agents responsible for it, and proposed solutions.
While there are some significant differences, particularly concerning the nature of the problem and the agents responsible for it, both pain medicine and addiction medicine authors 'take responsibility' in ways that attempt to mitigate the potential appropriation of the issue by law enforcement and regulatory agencies.
The responses of pain medicine and addiction medicine journal articles represent strategic moves to recapture lost credibility, to retain client populations and tools necessary to their jobs, and to claim a seat at the table in responding to the OxyContin crisis.
奥施康定（®）（普渡制药公司，斯坦福德，CT）现在被广泛认为是一种滥用药物，加剧了更大的阿片类药物健康危机。虽然北美媒体对奥施康定的报道主要集中在与犯罪、成瘾/滥用相关的问题上，以及执法官员和警察的观点上，但在与奥施康定关系最密切的医学领域，如疼痛医学和成瘾医学，报道则更为细致入微。
在本文中，我们借鉴了建构主义社会问题传统和亨特的道德监管理论，对 24 篇医学期刊文章进行了定性分析。我们比较和对比了疼痛医学和成瘾医学对奥施康定问题、负责该问题的代理机构以及提出的解决方案的描述。
虽然存在一些显著差异，特别是在问题的性质和负责该问题的代理机构方面，但疼痛医学和成瘾医学的作者都以试图减轻执法和监管机构可能对该问题进行干预的方式“承担责任”。
疼痛医学和成瘾医学期刊文章的反应代表了一种策略性的举措，旨在重新获得失去的信誉，保留患者群体和完成工作所需的工具，并在应对奥施康定危机时争取在决策中拥有一席之地。
